Recap: Laboratory Corp Q3 Earnings

Shares of Laboratory Corp LH moved higher by 0.5% in pre-market trading after the company reported Q3 results.

Quarterly Results

Earnings per share were up 190.00% over the past year to $8.41, which beat the estimate of $5.25.

Revenue of $3,896,000,000 up by 33.01% from the same period last year, which beat the estimate of $3,630,000,000.

Looking Ahead

Laboratory Corp hasn't issued any earnings guidance for the time being.

Laboratory Corp hasn't issued any revenue guidance for the time being.

How To Listen To The Conference Call

Date: Oct 27, 2020

Time: 09:00 AM

ET Webcast URL: https://edge.media-server.com/mmc/p/ps6cm2ir

Price Action

52-week high: $211.21

Company's 52-week low was at $98.02

Price action over last quarter: Up 3.78%

Company Overview

Laboratory Corporation of America is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from routine blood and urine screens to complex oncology and genomic testing. With the addition of Covance, LabCorp also has a sizable footprint in the global contract research organization market.